TLSI(TriSalus Life Sciences, Inc.) 的内部人交易:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-11-18 | Szela Mary T | CEO and President | 公开市场买入 | 34,328 | $2.59 |
| 2026-11-17 | Szela Mary T | CEO and President | 公开市场买入 | 30,864 | $2.31 |
| 2026-11-17 | Gordon Gary B. | 董事 | 公开市场买入 | 10,000 | $2.20 |
| 2026-11-16 | Marshak Richard | Chief Commercial Officer | 公开市场卖出 | 544 | $2.43 |
| 2026-11-12 | Wahlstrom Mats | 董事 | 公开市场买入 | 50,000 | $2.24 |
| 2026-10-05 | Cox Bryan F. | Chief of Research | 公开市场卖出 | 296 | $4.39 |
| 2026-10-05 | Marshak Richard | Chief Commercial Officer | 公开市场卖出 | 325 | $4.39 |
| 2026-10-05 | Stevens Jennifer | Chief Regulatory Officer | 公开市场卖出 | 316 | $4.39 |
| 2026-05-15 | Marshak Richard | Chief Commercial Officer | 公开市场卖出 | 543 | $2.67 |
| 2026-05-15 | Wahlstrom Mats | 董事 | 公开市场买入 | 60,000 | $2.53 |
| 2026-05-15 | Stansky Michael P | 董事 | 公开市场买入 | 200,000 | $2.50 |
| 2026-05-15 | Stansky Michael P | 董事 | 公开市场买入 | 410,000 | $2.50 |
| 2026-05-15 | Szela Mary T | CEO and President | 公开市场买入 | 39,682 | $2.59 |
| 2026-05-15 | Patience David | Chief Financial Officer | 公开市场买入 | 7,100 | $2.43 |
| 2026-05-15 | Gordon Gary B. | 董事 | 公开市场买入 | 10,000 | $2.46 |
| 2026-03-17 | Szela Mary T | CEO and President | 公开市场卖出 | 15,944 | $3.85 |
| 2026-03-16 | Devlin Jodi | Chief of Clinical Operations | 公开市场卖出 | 273 | $4.12 |
| 2026-03-16 | Cox Bryan F. | Chief of Research | 公开市场卖出 | 579 | $4.12 |
| 2026-03-16 | Marshak Richard | Chief Commercial Officer | 公开市场卖出 | 419 | $4.12 |
| 2026-03-16 | Stevens Jennifer | Chief Regulatory Officer | 公开市场卖出 | 774 | $4.12 |